Sunzen Biotech Bhd (0148) — Cash Flow Reinvestment Rate
Sunzen Biotech Bhd (0148) has a Cash Flow Reinvestment Rate of 0.04x as of September 2023, reinvesting RM145.00K (capex RM95.00K plus investments RM50.00K) from operating cash flow of RM3.58 Million. Check how high is Sunzen Biotech Bhd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sunzen Biotech Bhd Cash Flow Reinvestment Rate (2016–2023)
Historical reinvestment intensity for Sunzen Biotech Bhd across 4 annual periods. Explore 0148 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sunzen Biotech Bhd (2016–2023)
Year-by-year capital reinvestment analysis for Sunzen Biotech Bhd. For live market cap and broader valuation context, see 0148 market cap.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 2.96x | RM2.43 Million | RM819.39K | RM1.01 Million | ▲ +1495.8% |
| 2020 | 0.19x | RM1.34 Million | RM7.20 Million | RM1.16 Million | ▼ -87.5% |
| 2017 | 1.49x | RM5.98 Million | RM4.02 Million | RM3.42 Million | ▼ -95.7% |
| 2016 | 34.76x | RM8.90 Million | RM256.13K | RM6.64 Million | — |